Literature DB >> 17342177

Phenotypic transitions and fibrosis in diabetic nephropathy.

M S Simonson1.   

Abstract

The cause of renal fibrosis in diabetic nephropathy is widely believed to be phenotypic switching of fibroblasts to an activated state. However, emerging evidence suggests that diabetes also alters the phenotype of normal, non-fibroblast kidney cells, such as mesangial cells, tubular epithelial cells, and bone marrow-derived progenitors. Experiments have shown that cytokines, high glucose, and advanced glycation end products induce profibrotic changes in kidney cell phenotype by the processes of myofibroblast transdifferentiation and epithelial-mesenchymal transition. As a result, differentiated kidney cells become reprogrammed to secrete and accumulate extracellular matrix. This revised view implies that inhibiting phenotypic transitions in nonfibroblasts might limit fibrosis in diabetic nephropathy.

Entities:  

Mesh:

Year:  2007        PMID: 17342177     DOI: 10.1038/sj.ki.5002180

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  60 in total

1.  Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis.

Authors:  Jorge E Toblli; Gabriel Cao; Jorge F Giani; Margarita Angerosa; Fernando P Dominici; Nestor F Gonzalez-Cadavid
Journal:  Kidney Blood Press Res       Date:  2010-11-11       Impact factor: 2.687

2.  In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line.

Authors:  Romina Bertinat; Pamela Silva; Elizabeth Mann; Xuhang Li; Francisco Nualart; Alejandro J Yáñez
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

Review 3.  [Growth factors].

Authors:  N Hunzelmann; S Eming; S Rosenkranz
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

4.  Inhibitor of myogenic differentiation family isoform a, a new positive regulator of fibronectin production by glomerular mesangial cells.

Authors:  Parisa Yazdizadeh Shotorbani; Sarika Chaudhari; Yu Tao; Leonidas Tsiokas; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

5.  Role of protein kinase C in advanced glycation end products-induced epithelial-mesenchymal transition in renal proximal tubular epithelial cells.

Authors:  Shuwang Ge; Rui Zeng; Yun Luo; Lin Liu; Honglan Wei; Juan Zhang; Huan Zhou; Gang Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

Review 6.  microRNA regulation of Wnt signaling pathways in development and disease.

Authors:  Jia L Song; Priya Nigam; Senel S Tektas; Erica Selva
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

7.  Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus.

Authors:  Jorge E Toblli; Monica G Ferrini; Gabriel Cao; Dolores Vernet; Margarita Angerosa; Nestor F Gonzalez-Cadavid
Journal:  Nephrol Dial Transplant       Date:  2009-03-17       Impact factor: 5.992

Review 8.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

9.  Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.

Authors:  Chun-Liang Lin; Jeng-Yi Wang; Jih-Yang Ko; Yu-Ting Huang; Yu-Hsia Kuo; Feng-Sheng Wang
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

10.  Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells.

Authors:  Jin Wu; Changlin Mei; Helen Vlassara; Gary E Striker; Feng Zheng
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.